Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

NCT00563823 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: vatalanib

Sponsor

Cambridge University Hospitals NHS Foundation Trust